CompletedNot Applicable

Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease

France53 participantsStarted 2019-12-01

Plain-language summary

The aim is to evaluate the correlation of quantified fibro-adipous infiltration of muscles, using the MRI-based Mercuri score, with deficiencies, activity limitations and social participation in patients with arthrogryposis multiplex congenita.

Who can participate

Age range17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults * with a diagnostic of Amyoplasia or distal arthrogryposis * evaluated by a all body MRI * functionnal evaluation during day hospitalisation in neurorehabilitation department * between 2010 and october 2020 Exclusion Criteria: * other aetiology of Arthrogryposis multiplex congenita (AMC) * incomplete MRI or medical files * interaction with other disease

What they're measuring

Mercuri Scores of upper limbs, lower limbs,and trunk evaluated on MRI T1

Timeframe: during 5 day evaluation

Trial details

NCT IDNCT05137756

SponsorUniversity Hospital, Grenoble

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-07-01

View on ClinicalTrials.gov More Diagnosis of Arthrogryposis Amyoplasia or Distal Arthrogryposis trials